Compugen Ltd
NASDAQ:CGEN

Watchlist Manager
Compugen Ltd Logo
Compugen Ltd
NASDAQ:CGEN
Watchlist
Price: 1.41 USD -2.76% Market Closed
Market Cap: 126.3m USD
Have any thoughts about
Compugen Ltd?
Write Note

Compugen Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Compugen Ltd
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Compugen Ltd
NASDAQ:CGEN
Other Long-Term Assets
$1.6m
CAGR 3-Years
-5%
CAGR 5-Years
19%
CAGR 10-Years
32%
Q
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
Other Long-Term Assets
$300k
CAGR 3-Years
82%
CAGR 5-Years
27%
CAGR 10-Years
N/A
B
Biolight Life Sciences Ltd
TASE:BOLT
Other Long-Term Assets
â‚Ş251k
CAGR 3-Years
-37%
CAGR 5-Years
-46%
CAGR 10-Years
10%
No Stocks Found

Compugen Ltd
Glance View

Market Cap
126.2m USD
Industry
Life Sciences Tools & Services

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. The firm focuses on infrastructure to discover drug targets and develop therapeutics. The firm is engaged in the research, development and commercialization of therapeutic and product candidates. The firm's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs are focused on the development of cancer immunotherapy drugs with potential to harness the immune system to provide treatment solutions in areas of unmet medical needs in various cancer types and patient populations, both as monotherapy and in combination with other drugs. Its pipeline also includes a preclinical stage fusion protein autoimmune product candidate. Its fields of focus are oncology and immunology, with emphasis on its discovery capabilities on immuno-oncology.

CGEN Intrinsic Value
1 USD
Overvaluation 29%
Intrinsic Value
Price

See Also

What is Compugen Ltd's Other Long-Term Assets?
Other Long-Term Assets
1.6m USD

Based on the financial report for Sep 30, 2024, Compugen Ltd's Other Long-Term Assets amounts to 1.6m USD.

What is Compugen Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
32%

Over the last year, the Other Long-Term Assets growth was -14%. The average annual Other Long-Term Assets growth rates for Compugen Ltd have been -5% over the past three years , 19% over the past five years , and 32% over the past ten years .

Back to Top